PAX5 and cancer: However, PAX5 expression is low or lost in most human cancers such as childhood ependymoma, NSCLC, mesothelioma, pancreatic, esophageal, head and neck cancer, lymphoma, and lymphocytic leukaemia 13, 14, 15, 16.